Login / Signup

Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system.

Alberto De la Cuadra-GrandeJorge Rioja-ZuazuMario Domínguez-EstebanEsperanza TorresRob BlissettEmily WoodwardItziar OyagüezManuel Fernández-Arjona
Published in: Expert review of pharmacoeconomics & outcomes research (2023)
WVTT could reduce the cost of managing LUTS/BPH, increase the quality of health care and reduce the length of procedure and hospital stay.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • healthcare
  • quality improvement
  • minimally invasive
  • adverse drug
  • combination therapy
  • acute care
  • electronic health record